Investigation for Investors over Takeover of Celator Pharmaceuticals Inc (NASDAQ:CPXX) Announced

San Diego, CA -- (SBWIRE) -- 06/06/2016 -- An investigation on behalf of investors in shares of Celator Pharmaceuticals Inc (NASDAQ:CPXX), was announced over the acquisition of Celator Pharmaceuticals. by Jazz Pharmaceuticals plc for $30.25 per share.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.